Trial Profile
EVALUATION OF THE CLINICAL AND MICROBIOLOGICAL EFFICACY OF N-ACETILCISTEINA 600 MG, IN COMBINATION TO CEFPODOXIMA PROXETILE, IN THE THERAPY OF THE INFECTIONS OF THE HIGH RESPIRATORY WAYS IN ADULT PATIENTS CLINICAL STUDY MULTICENTRIC, TO GROUPS PARALLELS, DOUBLE - BLIND VS PLACEBO.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary) ; Cefpodoxime proxetil (Primary)
- Indications Bacterial infections; Pharyngitis; Respiratory tract infections; Rhinosinusitis; Tonsillitis
- Focus Therapeutic Use
- Sponsors Zambon Company SpA
- 22 Jul 2011 New trial record